Clinical Trials Logo

Clinical Trial Summary

The existing DBS setting in patients with DBS of the globus pallidus interna (GPi), which aims to treat motor symptoms by a high-frequency stimulation, will be temporarily reprogramed to stimulate the NbM at a low frequency using the distal electrodes positioned in the vicinity of the NBM.

This study aims to investigate the neuropsychological effect of low frequency stimulation of the nucleus basalis of Meynert (NBM) in advanced Parkinson's disease (PD) patients, who were previously treated with deep brain stimulation (DBS) of the globus pallidus interna (GPi).


Clinical Trial Description

The existing DBS setting in patients with GPi DBS, which aims to treat motor symptoms by a high-frequency stimulation, will be temporarily reprogramed to stimulate the NBM at a low frequency using the distal electrodes positioned in the vicinity of the NBM.This study consists of a three-day screening study of the NbM stimulation followed by a two-week, randomized, single-blind, crossover trial. Between the screening study and the crossover trial, one week of washout period will be applied to eliminate potential carryover effect from the previous stimulation.

This study aims to investigate the neuropsychological effect of low frequency stimulation of the nucleus basalis of Meynert (NBM) in advanced Parkinson's disease (PD) patients, who were previously treated with deep brain stimulation (DBS) of the globus pallidus interna (GPi). ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02763397
Study type Interventional
Source University Medical Center Groningen
Contact Muhammad Nazmuddin, MD
Email m.nazmuddin@umcg.nl
Status Not yet recruiting
Phase N/A
Start date May 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Completed NCT03695614 - Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia N/A
Active, not recruiting NCT05879562 - Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO N/A
Completed NCT03286439 - Recovery After Medical or Surgical Treatment
Recruiting NCT04251624 - Investigating the Use of Goal Management Therapy in Improving Cognitive Functioning in Public Safety Personnel With PTSD N/A
Recruiting NCT04051528 - Do Combinatorial Training Lead to Better Cognition and Daily Participation in TBI Persons With Cognitive Impairments N/A
Recruiting NCT03036319 - Patient-Centered NeuroRehabilitation (PCN) N/A
Recruiting NCT05251454 - Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects. N/A
Completed NCT05063669 - Cognitive Intervention in Attention Deficit and Hyperactivity Disorder N/A
Completed NCT02964221 - Cognitive Changes After Major Joint Replacement N/A
Not yet recruiting NCT05605366 - Minocycline In Neurocognitive Outcomes - Sickle Cell Disease Phase 1
Completed NCT02214342 - Virtual Reality Based Balance Training in People With Mild Cognitive Impairment N/A
Terminated NCT03032471 - Swiss SOS MoCA - DCI Study
Recruiting NCT04456777 - Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia Early Phase 1
Recruiting NCT04204239 - Validation Study SCOBES-AR
Withdrawn NCT04457271 - Goal Management Training in Individuals With PTSD N/A
Terminated NCT03034109 - Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits N/A
Recruiting NCT05802680 - Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation N/A
Active, not recruiting NCT02847403 - Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients Phase 3
Withdrawn NCT04654130 - Neurofeedback Effectiveness Trial in PTSD N/A